Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 19;7(1):3777.
doi: 10.1038/s41598-017-03716-7.

Looking to nature for a new concept in antimicrobial treatments: isoflavonoids from Cytisus striatus as antibiotic adjuvants against MRSA

Affiliations

Looking to nature for a new concept in antimicrobial treatments: isoflavonoids from Cytisus striatus as antibiotic adjuvants against MRSA

Ana Cristina Abreu et al. Sci Rep. .

Abstract

The spread of multidrug-resistant Staphylococcus aureus strains, including methicillin-resistant S. aureus (MRSA), has shortened the useful life of anti-staphylococcal drugs enormously. Two approaches can be followed to address this problem: screening various sources for new leads for antibiotics or finding ways to disable the resistance mechanisms to existing antibiotics. Plants are resistant to most microorganisms, but despite extensive efforts to identify metabolites that are responsible for this resistance, no substantial progress has been made. Plants possibly use multiple strategies to deal with microorganisms that evolved over time. For this reason, we searched for plants that could potentiate the effects of known antibiotics. From 29 plant species tested, Cytisus striatus clearly showed such an activity and an NMR-based metabolomics study allowed the identification of compounds from the plant extracts that could act as antibiotic adjuvants. Isoflavonoids were found to potentiate the effect of ciprofloxacin and erythromycin against MRSA strains. For the structure-activity relationship (SAR), 22 isoflavonoids were assessed as antibiotic adjuvants. This study reveals a clear synergy between isoflavonoids and the tested antibiotics, showing their great potential for applications in the clinical therapy of infections with antibiotic-resistant microorganisms such as MRSA.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Potentiating effects of ciprofloxacin and erythromycin obtained when combined with the different extracts of Cytisus striatus against Staphylococcus aureus CECT 976. The activity is expressed as the increase in the inhibition zone diameter (IZD, mm) caused by ciprofloxacin (a) and erythromycin (b) in the presence of the extracts of C. striatus dissolved in Mueller-Hinton agar medium. Bars represent means and SD from at least three independent experiments. The sample parameters (x,y) are shown in Supplementary Table 2.
Figure 2
Figure 2
Orthogonal partial least squares modeling applied to 1H-NMR data and potentiating activity of Cytisus striatus samples (Fig. 2). OPLS score- and S-plots obtained from the potentiating activity (1: indifferent formula image, 2: additive formula image and 3: potentiation effect formula image) and 1H-NMR data in the range of the region between δ 6.00 and 8.60 of the different classes of potentiating activity of extracts of C. striatus on ciprofloxacin (a) and erythromycin (b). The sample preparation and extraction conditions were performed as shown in Supplementary Table 2.
Figure 3
Figure 3
Effect of isoflavonoids on EtBr accumulation in Staphylococcus aureus SA1199B. In (a), fluorescence as a measure of EtBr accumulation is shown for all Staphylococcus aureus strains for 60 min at 37 °C; EtBr was applied at ½ MIC and fluorescence measurement obtained by fluorometric method; in (b), only the isoflavonoids (60 µg/mL) increasing the accumulation of EtBr in SA1199B cultures over control over time (P < 0.05) are represented; the changes in the accumulation of EtBr in SA1199B are also shown for genistein, tectorigenin (both at 60 µg/mL) and orobol (30 µg/mL) (c) and for the flavonoids apigenin and chrysin (d). Reserpine at 20 µg/mL was used as a positive control as efflux pump inhibitor (EPI). Mean values of least three independent experiments are shown.

Similar articles

Cited by

References

    1. Kourtesi C, et al. Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. Open Microbiol. J. 2013;7:34–52. doi: 10.2174/1874285801307010034. - DOI - PMC - PubMed
    1. Piddock LJV, Garvey MI, Rahman MM, Gibbons S. Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria. J. Antimicrob. Chemother. 2010;65:1215–1223. doi: 10.1093/jac/dkq079. - DOI - PubMed
    1. Clardy J, Fischbach MA, Walsh CT. New antibiotics from bacterial natural products. Nat. Biotechnol. 2006;24:1541–1550. doi: 10.1038/nbt1266. - DOI - PubMed
    1. Gibbons S, Moser E, Kaatz GW. Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus. Planta Med. 2004;70:1240–1242. doi: 10.1055/s-2004-835860. - DOI - PubMed
    1. Tegos G, Stermitz FR, Lomovskaya O, Lewis K. Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob. Agents Chemother. 2002;46:3133–3141. doi: 10.1128/AAC.46.10.3133-3141.2002. - DOI - PMC - PubMed

Publication types

MeSH terms

  NODES
twitter 2